Figure 2From: Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis Differences between mean effects of MK-3641 and placebo on TCS during peak ragweed pollen season in the Canadian subgroup and the entire population in two trials. Back to article page